Early preclinical development of Mycobacterium tuberculosis amino acid biosynthesis pathway inhibitor DRILS-1398 as a potential anti-TB drug.
结核分枝杆菌氨基酸生物合成途径抑制剂 DRILS-1398 作为潜在抗结核药物的早期临床前开发
期刊:iScience
影响因子:4.1
doi:10.1016/j.isci.2025.112537
Biswas Deepesh, Edwin Rebecca Kristina, Kumar K Shiva, Alam Anwar, Kumar Dhiraj, Chakraborty Sandipan, Bulusu Gopalakrishnan, Ahmad Farhan Jalees, Shenoy Gautham G, Singh Lakshyaveer, Agarwal Mansi, Siraj Fouzia, Oruganti Srinivas, Misra Parimal, Ehtesham Nasreen Zafar, Pal Manojit, Hasnain Seyed Ehtesham